[The effect of various factors on the results of chemotherapy in patients with recurrent ovarian serous cystadenocarcinoma].
The results of chemotherapy (frequency and duration of remission) of 237 cases of primary and 119-recurrent serous cystadenocarcinoma of ovaries are discussed.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003536:Cystadenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D005260:Female; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D011379:Prognosis; D013852:Thiotepa / Q000008:administration & dosage; D013997:Time Factors; D014227:Triazines / Q000008:administration & dosage
D000970:Antineoplastic Agents; D014227:Triazines; C040269:dioxadet; D003520:Cyclophosphamide; D013852:Thiotepa; D008558:Melphalan
O vliianii nekotorykh faktorov na rezul'taty khimioterapii bol'nykh retsidivami seroznoĭ tsistadenokartsinomoĭ iaichnikov.